PROGRAM | Friday, December 10, 2021

The certification will be applied for with the Medical Association of Saxony.

08:30–10:00 am
Organ specific lipid handling
Chairs: J. Thiery | B. Isermann

The certification will be applied for with the Medical Association of Saxony.

10:00–10:15 am | Coffee Break

10:15–11:15 am
Lipids and liver cell biochemistry
Chairs: T. Schöneberg | M. Matz-Soja

10:15–11:15 am
Lipidomics for patient stratefication
Chairs: U. Ceglarek | A. von Eckardstein

11:15–11:35 am | Short Break

11:35–12:35 pm
Lipid metabolism and NASH
Chairs: T. Kaiser | J. Wiegand

11:35–12:35 pm
Diet, lipid metabolism and diseases
Chairs: R. Burkhardt | J.-R. Nofer

12:45–02:30 pm | Lunch Break

02:30–04:00 pm
Lipid metabolism in cardiovascular disease
Chairs: U. Laufs | M. Stumvoll

04:00–04:30 pm | Coffee Break

04:30–05:10 pm
Mechanisms of atherosclerosis
Chairs: S. Herzig | J. N. Boeckel

04:30–05:10 pm
Adipose tissue – more than a sink for lipids
Chairs: M. Blüher | B. Sheikh

05:10–06:25 pm
Chairs: P. Büttner | M. Matz-Soja | K. Shahzad | O. Tiebel

08:00 pm | Christmas Oratorio

08:30 – 09:00 am	Lipid handling by endothelial cells of thermogenic adipose tissue J. Herren
09:00 – 09:30 am	Lipoproteins in chronic kidney disease T. Speer
09:30 – 10:00 am	Metabolic liver disease in diabetes – From mechanisms to clinical trials S. Herzig

10:15 – 10:35 am	Monitoring lipid localisation and molecular identity in cellular transport processes A. Nadler
10:35 – 10:55 am	Structural insights into EHD-mediated membrane remodelling and its role in regulating cellular fatty acid uptake O. Daumke
10:55 – 11:15 am	Quality control of the mitochondrial proteome (including regulation of lipid metabolism) T. Becker

10:15 – 10:35 am	Omics – Stratifizierung für die Akutmeidzin? M. Bauer
10:35 – 10:55 am	Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes R. Wagner
10:55 – 11:15 am	Cardiogenic shock – new objective prognosis estimation by the CLIP-score H. Thiele

11:35 – 11:55 am	Hepatic lipid droplet homeostasis and fatty liver disease N. Krahmer
11:55 – 12:15 pm	Cell-based strategies against fatty liver B. Christ
12:15 – 12:35 pm	Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism F. Tacke

11:35 – 11:55 am	Challenges in clinical lipidomics studies M. Haid
11:55 – 12:15 pm	Can we treat metabolic diseases with diet? M. Blüher
12:15 – 12:35 pm	The effect of Green-MED diet on microbiome and intra-hepatic fat I. Shai

02:30 – 03:00 pm	Myeloid cells in cardiovascular health M. Nahrendorf
03:00 – 03:30 pm	Platelet lipidomics, atherosclerosis, coronary artery disease M. Gawaz
03:30 – 04:00 pm	Inflammation and atherosclerosis – new mechanisms P. Libby

04:30 -04:50 pm	The role of red cell eNOS signaling in blood / vessel interactions and systemic hemodynamics M. Cortese-Krott
04:50 – 05:10 pm	Marcophage proliferation during plaque regression in response to cholesterol lowering I. Hilgendorf

04:30 – 04:50 pm	Single cell approaches to understand adipose tissue function S. Mandrup
04:50 – 05:10 pm	Adipose tissue at the cross roads of metabolism and inflammation J. Ferno